GRASSILLI, Silvia
 Distribuzione geografica
Continente #
NA - Nord America 1.727
EU - Europa 858
AS - Asia 317
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.903
Nazione #
US - Stati Uniti d'America 1.723
IT - Italia 366
PL - Polonia 296
CN - Cina 161
UA - Ucraina 62
TR - Turchia 59
SG - Singapore 56
DE - Germania 46
GB - Regno Unito 31
ID - Indonesia 22
FI - Finlandia 16
SE - Svezia 16
VN - Vietnam 12
BE - Belgio 11
FR - Francia 11
CA - Canada 4
IN - India 4
HK - Hong Kong 2
EU - Europa 1
GR - Grecia 1
IR - Iran 1
NL - Olanda 1
RU - Federazione Russa 1
Totale 2.903
Città #
Warsaw 296
Fairfield 273
Ferrara 237
Woodbridge 216
Ann Arbor 153
Chandler 118
Houston 110
Ashburn 109
Seattle 103
Cambridge 93
Wilmington 79
Jacksonville 76
Beijing 45
Izmir 44
New York 39
Princeton 36
Singapore 30
Shanghai 29
Nanjing 25
Jakarta 22
Addison 21
San Diego 18
Bologna 12
Dong Ket 12
Boardman 11
Brussels 10
Nanchang 10
Bremen 9
Dearborn 9
Milan 9
Rimini 9
Auburn Hills 8
Los Angeles 7
Shenyang 7
Ariano nel Polesine 6
Chicago 6
Mountain View 5
Norwalk 5
Cagliari 4
Changsha 4
Hebei 4
Hounslow 4
Rome 4
San Mateo 4
Treviso 4
Falls Church 3
Hefei 3
Jiaxing 3
Jinan 3
Kunming 3
London 3
Monmouth Junction 3
Savignano sul Rubicone 3
Tianjin 3
Toronto 3
Zhengzhou 3
Arezzo 2
Augusta 2
Ferrara di Monte Baldo 2
Florence 2
Haikou 2
Hangzhou 2
Helsinki 2
Hong Kong 2
Leawood 2
Modena 2
Munich 2
Orange 2
Ozzano dell'Emilia 2
Parma 2
Pegola 2
Redwood City 2
San Mauro Pascoli 2
Vazzola 2
Venice 2
Washington 2
Ardabil 1
Bangalore 1
Bentivoglio 1
Castel di Casio 1
Changchun 1
Cremenaga 1
Crotone 1
Delhi 1
Des Moines 1
Imola 1
Kilburn 1
Lanzhou 1
Lappeenranta 1
Montreal 1
Nagold 1
Ningbo 1
Osio Sotto 1
Palermo 1
Pasadena 1
Philadelphia 1
Prescot 1
Redmond 1
Rubano 1
San Francisco 1
Totale 2.432
Nome #
RUOLO DI VAV1 NELLA MATURAZIONE DI PROMIELOCITI TUMORALI APL-DERIVATI 177
A network including PU.1, Vav1 and miR-142-3p sustains ATRA-induced differentiation of acute promyelocytic leukemia cells - a short report 155
In triple negative breast tumor cells, PLC-beta 2 promotes the conversion of CD133(high) to CD133(low) phenotype and reduces the CD133-related invasiveness 136
null 134
Vav1 is necessary for PU.1 mediated upmodulation of miR-29b in acute myeloid leukaemia-derived cells 132
Ectopic expression of PLC-β2 in non-invasive breast tumor cells plays a protective role against malignant progression and is correlated with the deregulation of miR-146a 120
Up-modulation of PLC-beta2 reduces the number and malignancy of triple-negative breast tumor cells with a CD133+/EpCAM+ phenotype: A promising target for preventing progression of TNBC 118
High nuclear level of Vav1 is a positive prognostic factor in early invasive breast tumors: a role in modulating genes related to the efficiency of metastatic process 116
Risk factors associated with relapse of eyelid basal cell carcinoma: results from a retrospective study of 142 patients 115
Vav1 is a crucial molecule in monocytic/macrophagic differentiation of myeloid leukemia-derived cells 111
Vav1 downmodulates Akt in different breast cancer subtypes: A new promising chance to improve breast cancer outcome 111
Protective role of all-trans retinoic acid (ATRA) against hypoxia-induced malignant potential of non-invasive breast tumor derived cells 109
Mass spectrometry-based identification of Y745 of Vav1 as a tyrosine residue crucial in maturation of acute promyelocytic leukemia-derived cells 107
CD133 in Breast Cancer Cells: More than a Stem Cell Marker 105
Vav1 and PU.1 are recruited to the CD11b promoter in APL-derived promyelocytes: Role of Vav1 in modulating PU.1-containing complexes during ATRA-induced differentiation 103
Nuclear proteome analysis reveals a role of Vav1 in modulating RNA processing during maturation of tumoral promyelocytes 102
Vav1 in differentiation of tumoral promyelocytes 101
Levels of miR-126 and miR-218 are elevated in ductal carcinoma in situ (DCIS) and inhibit malignant potential of DCIS derived cells 99
Vav1 modulates protein expression during ATRA-induced maturation of APL-derived promyelocytes: a proteomic-based analysis. 98
hnRNP K in PU.1-containing complexes recruited at theCD11bpromoter: a distinct role in modulating granulocytic and monocytic differentiation of AML-derived cells 97
RNA interference in the study of molecular mechanisms activated during agonist induced differentiation of acute promyelocytic leukemia derived promyelocytes 76
Pulsed Electromagnetic Fields Modulate miRNAs During Osteogenic Differentiation of Bone Mesenchymal Stem Cells: a Possible Role in the Osteogenic-angiogenic Coupling 59
Dysregulation of Transglutaminase type 2 through GATA3 defines aggressiveness and Doxorubicin sensitivity in breast cancer 50
Ethanol-based garlic extract prevents malignant evolution of non-invasive breast tumor cells induced by moderate hypoxia 47
Vav1 Down-Modulates Akt2 Expression in Cells from Pancreatic Ductal Adenocarcinoma: Nuclear Vav1 as a Potential Regulator of Akt Related Malignancy in Pancreatic Cancer 36
The Molecular Networks of microRNAs and Their Targets in the Drug Resistance of Colon Carcinoma 36
Vav1 Sustains the In Vitro Differentiation of Normal and Tumor Precursors to Insulin Producing Cells Induced by all-Trans Retinoic Acid (ATRA) 33
Deregulated microRNAs in breast ductal carcinoma in situ (DCIS) with invasive propensity 32
In triple negative breast tumor cells, PLC-β2 promotes the conversion of CD133high to CD133low phenotype and reduces the CD133-related invasiveness 31
The Motility and Mesenchymal Features of Breast Cancer Cells Correlate with the Levels and Intracellular Localization of Transglutaminase Type 2 28
A Multidisciplinary Approach Establishes a Link between Transglutaminase 2 and the Kv10.1 Voltage-Dependent K+ Channel in Breast Cancer 26
Targeting the Vav1/miR‐29b axis as a potential approach for treating selected molecular subtypes of triple‐negative breast cancer 26
ROLE OF VAV1 IN DIFFERENTIATION ALONG THE MONOCYTIC-MACROPHAGIC LINEAGE OF TUMORAL MYELOID PRECURSORS 22
Effects of garlic extract on breast tumor cells: a phenotype dependent modulation of morphology, cell cycle and invasive potential 20
PLC-β2 is modulated by low oxygen availability in breast tumor cells and plays a phenotype dependent role in their hypoxia-related malignant potential 19
EVALUATION OF DIFFERENT STORAGE CONDITIONS ON CHEMICAL COMPOSITION AND BIOACTIVE COMPOUNDS OF VOGHIERA GARLIC PDO 18
The Effect of Different Storage Conditions on Phytochemical Composition, Shelf-Life, and Bioactive Compounds of Voghiera Garlic PDO 18
Vav1 regulates phenotypic differentiation of AML-derived promyelocytes to monocytes/macrophages 18
Transcriptomics Studies Reveal Functions of Transglutaminase 2 in Breast Cancer Cells Using Membrane Permeable and Impermeable Inhibitors 17
THE MULTIDOMAIN PROTEIN VAV1 IN THE DIFFERENTIATION OF PLURIPOTENT STEM CELLS TO INSULIN-PRODUCING CELLS 12
Convolvulus pluricaulis Choisy’s Extraction, Chemical Characterization and Evaluation of the Potential Effects on Glycaemic Balance in a 3T3-L1 Adipocyte Cell Model 12
Investigating intra- and extra-cellular functions of Transglutaminase 2 by use of inhibitors with different localization in breast cancer cells 11
Vav1 Selectively Down-Regulates Akt2 through miR-29b in Certain Breast Tumors with Triple Negative Phenotype 7
Mir-29b in Breast Cancer: A Promising Target for Therapeutic Approaches 6
Phenotype-dependent role of Vav1 in down-modulating Akt in invasive breast tumor cells 5
Traditional versus progressive robot-assisted gait training in people with multiple sclerosis and severe gait disability: study protocol for the PROGR-EX randomised controlled trial 3
Totale 3.014
Categoria #
all - tutte 14.173
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.173


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020544 0 25 29 78 39 57 57 69 62 59 44 25
2020/2021649 26 29 35 39 133 77 64 72 18 76 38 42
2021/2022333 12 24 30 17 9 32 23 16 8 43 22 97
2022/2023316 36 19 21 29 41 27 22 49 36 2 20 14
2023/2024321 18 26 3 10 20 60 12 43 8 13 23 85
2024/202571 52 19 0 0 0 0 0 0 0 0 0 0
Totale 3.014